Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: VBIO) | Delayed: 1.12 -0.07 (5.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.19 | 52 Week High | $1.84 | |||
| Open | $1.20 | 52 Week Low | $0.61 | |||
| Day High | $1.20 | P/E | N/A | |||
| Day Low | $1.10 | EPS | $0.00 | |||
| Volume | 203,139 | |||||
